
Scientific Job Openings | ||||
| Listed: 2026-10-08 | ||||
Bachelor/Master thesis project: |
||||
How to regulate the duration of mitosis and control cell fate decisions |
||||
Every day, millions of cells undergo mitosis in our bodies to support growth and replace damaged cells. Therefore, numerous safeguards have evolved to ensure that genomic stability is maintained. Recent findings support that time spent in mitosis is measured and can affect cell fate decisions, if mitotic timing is abnormally extended. However, it is still not clear how cells are able to monitor mitotic duration and translate this into cell fate decisions. Recent findings have proposed pathways that can monitor mitotic length and lead to a p53-mediated arrest if a timing threshold is surpassed, even in the absence of DNA damage. This mechanism can prevent repeated damaged cells from proliferating and prevent cycles of chromosomal instability. Recent findings in the Schiebel lab identified that upon prolonged mitosis the protein kinase HIPK2, a known p53 activator, could indirectly influence Cyclin B1 levels to further maintain mitotic arrest. Except for HIPK2, CDC14B is also involved in the regulation of Cyclin B1 and the overall progression of mitosis. CDC14 is a phosphatase that has been widely studied in Saccharomyces cerevisiae (ScCDC14) for its central role in mitotic exit and cytokinesis. But its role in human cells is largely understudied. In this project, we aim to investigate the role of HIPK2 and CDC14B in mitosis and mitotic arrest, and explore novel interactors of these proteins. We believe that understanding this mechanism, which plays an important part in preventing cancerous cells from spreading, could improve detection and therapy of cancer. Please send application with CV and a short statement of interests to Prof. Dr. Elmar Schiebel, ZMBH, Uni Heidelberg.
Techniques that will be used in this project:
Related literature:
|
||||
Non-Scientific Job Openings |
||||
|
|
||||